Replies to post #84348 on $heff's $tation of $tocks & $olid DD

[biotechrocks2005]

$CLRB granted orphan drug by FDA for Multiple Myeloma

Disclosure: Long CLRB

Good news for the company! If I'm not mistaken part of the orphan drug designation is the FDA reviewing the clinical work done so far, as well as it being an underserved population.

Again, caution to anyone looking into this- very low float, oftentimes very, very low volume. May be worth keeping on radar into 2015 as there is a pivotal trial on Glioblastoma. In my opinion there is a high chance of success- the imaging side has always worked in the preclinical and clinical data so far.